Cytokine treatment of macrophage suppression of T cell activation

Immunobiology

Volumn 215, Issue 1, 2010, Pages 70-80

  Silberman, Daniel ^a   Bucknum, Amanda ^a   Kozlowski, Megan ^a   Matlack, Robin ^a   Riggs, James ^a  

^a RIDER UNIVERSITY   (United States)

Author keywords

Cytokines; Macrophages; Suppression

Indexed keywords

AMINO ACID; ARGININE; B7 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 3; LIGAND; LYMPHOCYTE ANTIGEN; PROSTAGLANDIN SYNTHASE; TRYPTOPHAN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CATABOLISM; CELL SUSPENSION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME SYNTHESIS; FEMALE; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; CELL COMMUNICATION; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNE TOLERANCE; IMMUNOTHERAPY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, SCID; MINOR LYMPHOCYTE STIMULATORY ANTIGENS; NEOPLASMS; NITRIC OXIDE SYNTHASE TYPE II; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 70350062736     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.01.015     Document Type: Article

References (58)

1. + T lymphocyte responses. J. Immunol. 172 (2004) 3725-3735
2. Apolloni E., Bronte V., Mazzoni A., Serafini P., Cabrelle A., Segal D., Young H., and Zanovello P. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J. Immunol. 165 (2000) 6723-6730
3. Ardavin C., Waanders G., Ferrero I., Anjuere F., Acha-Orbea H., and MacDonald H. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells. J. Immunol. 157 (1996) 2789-2794
4. Balkwill F., Charles K., and Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7 (2005) 211-217
5. Bronte V., and Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5 (2005) 641-654
6. Bunt S., Sinha P., Clements V., Leips J., and Ostrand-Rosenberg S. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 176 (2006) 284-290
7. Butte M., Keir M., Phamduy T., Sharpe A., and Freeman G. Programmed death-ligand 1 interacts specifically with B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27 (2007) 111-122
8. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat. Rev. Immunol. 4 (2004) 336-350
9. Choi Y., Kappler J., and Marrack P. A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumor virus superantigen. Nature 350 (1991) 203-207
10. Collins A., Brodie D., Gilbert R., Laboni A., Manso-Sancho R., Walse B., Stuart D., Anton van der Merwe P., and Davis S. The interaction properties of costimulatory molecules revisited. Immunity 17 (2002) 201-210
11. Curiel T., Wei S., Dong H., Alvarez X., Cheng P., Mottram P., Krzysiek R., Knutson K., Daniel B., Zimmerman M., David O., Burrow M., Gordon A., Dhurandhar N., Myers L., Berggren R., Hemminki A., Alvarez R., Emilie D., Curiel D., Chen L., and Zou W. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 5 (2003) 562-567
12. Drake C., Jaffee E., and Pardoll D. Mechanisms of immune evasion by tumors. Adv. Immunol. 90 (2006) 51-81
13. Fallarino F., Grohmann U., Hwang K., Orabona C., Vacca C., Bianchi R., Belladonna M., Fioretti M., Alegre M., and Puccetti P. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4 (2003) 1206-1212
14. Fu Y.-X., Watson G., Kasahara M., and Lopez D. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF. J. Immunol. 146 (1991) 783-789
15. + T helper lymphocytes. Eur. J. Immunol. 23 (1993) 2365-2371
16. Goni O., Alcaide P., and Fresno M. Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+)CD11b(+)) immature myeloid suppressor cells. Int. Immunol. 14 (2002) 1125-1134
17. Gordon S., and Taylor P. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5 (2005) 953-964
18. Grohmann U., Fallarino F., Bianchi R., Belladonna M., Vacca C., Orabona C., Uyttenhove C., Fioretti M., and Puccetti P. IL-6 inhibits the tolerogenic function of CD8α dendritic cells expressing indoleamine 2,3-dioxygenase. J. Immunol. 167 (2001) 708-714
19. Hopken U., Lehmann I., Droese J., Lipp M., Schuler T., and Rehm A. The ratio between dendritic cells and T cells determines the outcome of their encounter: proliferation versus deletion. Eur. J. Immunol. 35 (2005) 2851-2863
20. Jarvis C., Germain R., Hager G., Damschroder M., and Matis L. Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens. J. Immunol. 152 (1994) 1032-1038
21. Korman A., Peggs K., and Alllison J. Checkpoint blockade in cancer immunotherapy. Adv. Immunol. 90 (2006) 297-339
22. Kuroda E., Noguchi J., Doi T., Uematsu S., Akira S., and Yamashita U. IL-3 is an important differentiation factor for the development of prostaglandin E2-producing macrophages between C57BL/6 and BALB/c mice. Eur. J. Immunol. 37 (2007) 2185-2195
23. Lagasse E., and Weissman I. Flow cytometric identification of murine neutrophils and monocytes. J. Immunol. Meth. 197 (1996) 139-150
24. Larsson-Sciard F., Spetz-Hagberg A., Casrouge A., and Kourilsky P. Analysis of T cell receptor Vβ usage in primary mixed lymphocyte reactions: evidence for directive usage by different antigen-presenting cells and Mls-like determinants on T cell blasts. Eur. J. Immunol. 20 (1990) 1223-1229
25. Lohr J., Knoechel B., Jiang S., Sharpe A., and Abbas A. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat. Immunol. 4 (2003) 664-669
26. Luther S., and Acha-Orbea H. Mouse mammary tumor virus: immunological interplays between virus and host. Adv. Immunol. 65 (1997) 139-243
27. a encoded antigens. Nature 332 (1988) 40-54
28. Martinez, F.O., Helming, L., Gordon, S., 2008, December 23. [Epub ahead of print]. Alternative activation of macrophages: an immunological perspective. Ann. Rev. Immunol.
29. Matlack R., Yeh K., Rosini L., Gonzalez D., Taylor J., Silberman D., Pennello A., and Riggs J. Peritoneal macrophages suppress T cell activation by amino acid catabolism. Immunology 117 (2006) 386-395
30. Mencacci A., Montagnoli C., Bacci A., Cenci E., Pitzurra L., Spreca A., Kopf A., Sharp A., and Romani L. CD80+ Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. J. Immunol. 169 (2002) 3180-3190
31. Miyake Y., Asano K., Kaise H., Uemura M., Nakayama M., and Tanaka M. Critical role of macrophages in the marginal zone in suppression of immune responses to apoptotic cell-associated antigens. J. Clin. Invest. 117 (2007) 2268-2278
32. Molina I., Cannon N., Hyman R., and Huber B. Macrophages and T cells do not express Mlsa determinants. J. Immunol. 143 (1989) 39-43
33. Mosmann T., and Coffman R. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 7 (1989) 145-173
34. Mosser D., and Edwards J. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8 (2008) 958-969
35. Munn D., Shafizadeh E., Attwood J., Bondarev I., Pashine A., and Mellor A. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189 (1999) 1363-1372
36. Nonaka K., Saoi M., Suwa T., Frey A., Umemura N., Imai H., Ouyang G., Osada S., Balazs M., Adany R., Kawaguchi Y., Yoshida K., and Takami T. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. J. Leuk. Biol. 84 (2008) 679-688
37. Orabona C., Grohmann U., Belladonna M., Fallarin F., Vacca C., Bianchi R., Bozza S., Volpi C., Salomon B., Fioretti M., Romani L., and Puccetti P. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol. 5 (2004) 1134-1142
38. Pasare C., and Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299 (2003) 1033-1036
39. Pentcheva-Hoang T., Egen J., Wojnoonski K., and Allison J. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 21 (2004) 401-413
40. +-adaptive regulatory T cell generation. J. Immunol. 180 (2008) 6566-6576
41. Pollard J. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Revs. Cancer 4 (2004) 71-78
42. Rabinovich G., Gabrilovich D., and Sotomayor E. Immunosuppressive strategies that are mediated by tumor cells. Ann. Rev. Immunol. 25 (2007) 267-296
43. Riggs J., Howell K., Taylor J., Mahjied T., Prokopenko N., Alvarez J., and Coleman C. Mls presentation by peritoneal cavity B cells. Immunobiology 209 (2004) 255-264
44. + T cells. Immunobiology 209 (2004) 513-522
45. Rosini L., Matlack R., Taylor J., Howell K., Yeh K., Pennello A., and Riggs J. Nonlymphoid peritoneal cells suppress the T cell response to Mls. Immunobiology 209 (2004) 575-584
46. Rossner S., Voigtlander C., Wiethe C., Hanig J., Seifarth C., and Lutz M. Myeloid dendritic cell precursors generated from bone marrow suppresses T cell responses via cell contact and nitric oxide production in vitro. Eur. J. Immunol. 35 (2005) 3533-3544
47. Serafini P., Borrello I., and Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Sem. Cancer Biol. 16 (2005) 53-65
48. Serafini P., Carbley R., Noonan K., Tan G., Bronte V., and Borrello I. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64 (2004) 6337-6343
49. Shimizu T., Sano C., and Tomioka H. The role of B7 molecules in the cell contact-mediated suppression of T cell mitogenesis in immunosuppressive macrophages induced with mycobacterial infection. Clin. Exp. Immunol. 35 (2004) 373-379
50. Steinman R., Hawiger D., and Nussenzweig M. Tolerogenic dendritic cells. Ann. Rev. Immunol. 21 (2003) 685-711
51. Waldmann T. Effective cancer therapy through immunodulation. Ann. Rev. Med. 57 (2006) 65-81
52. + T cell regulatory functions. J. Immunol. 178 (2007) 271-279
53. Webb S., Okamoto A., Ron Y., and Sprent J. Restricted tissue distribution of Mls-a determinants. Stimulation of Mls-a-reactive T cells by B cells but not by dendritic cells or macrophages. J. Exp. Med. 169 (1989) 1-12
54. Xu G., Zhang Y., Zhang L., Ren G., and Shi Y. The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells. Biochem. Biophys. Res. Commun. 361 (2007) 745-750
55. Yamazaki T., Akiba H., Iwai H., Matsuda H., Aoki M., Tanno Y., Shin T., Tsuchiya H., Pardoll D., Okumura K., Azuma M., and Yagita H. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169 (2002) 5538-5545
56. + myeloid cells. Cancer Res. 66 (2006) 6807-6815
57. Yeh K., Silberman D., Gonzalez D., and Riggs J. Complementary suppression of T cell activation by peritoneal macrophages and CTLA-4-Ig. Immunobiology 212 (2007) 1-10
58. Zou W., and Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat. Rev. Immunol. 8 (2008) 467-477